Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin’s Lymphomas

Journal of Nuclear Medicine

Steven W. Lamberts¹  Roelf Valkema¹  Eric P. Krenning¹  Pieternella J. Lugtenburg¹  Wim L. van Putten¹  Bob Löwenberg¹  Hong-Yoe Oei¹  Marinus J. Eijkemans¹ 

[1] Departments of Hematology, Nuclear Medicine, Internal Medicine, Public Health, and Statistics, Erasmus University; and University Hospital Rotterdam, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Departments of Hematology, Nuclear Medicine, Internal Medicine, Public Health, and Statistics, Erasmus University; and University Hospital Rotterdam, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands Departments of Hematology, Nuclear Medicine, Internal Medicine, Public Health, and Statistics, Erasmus University; and University Hospital Rotterdam, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

关键词: somatostatin receptor scintigraphy;    low-grade non-Hodgkin’s lymphoma;    staging;   

DOI  :  

学科分类：医学（综合）

来源: Society of Nuclear Medicine

【 摘 要 】

In this prospective study, somatostatin receptor (SS-R) scintigraphy was compared with conventional staging procedures for the initial staging of patients with low-grade non-Hodgkin’s lymphoma (NHL). Methods: Fifty consecutive untreated patients with low-grade NHL underwent SS-R scintigraphy as part of their initial staging. Planar images were obtained 24 and 48 h after intravenous injection of 220 MBq 111In-pentetreotide. SPECT images of the upper abdomen were obtained from all patients. SS-R scans were evaluated blindly without knowledge of the results of the conventional staging methods. SS-R scintigraphy findings were compared with the results of physical and radiologic examinations. Results: SS-R scintigraphy findings were positive in 42 of 50 patients (84%). In 10 patients (20%), the SS-R scan revealed new lesions that had not been revealed by conventional staging procedures. These 10 patients were all upgraded to a higher stage. Consequently, the treatment plan would have been altered in 5 patients (10%). However, in 19 patients (38%), lesions apparent after conventional staging methods were missed by SS-R scintigraphy. The sensitivity of SS-R scintigraphy varied from 62% for supradiaphragmatic lesions to 44% for infradiaphragmatic lesions. The specificity of SS-R scintigraphy was high (98%–100%). In comparison with CT scanning and sonography, SS-R scintigraphy is inferior for the visualization of NHL lesions in the thorax and abdomen. Conclusion: Although SS-R scintigraphy findings are positive in a large proportion of patients with low-grade NHL, in most patients only part of the lesions can be visualized. Because of the limited sensitivity, we recommend SS-R scintigraphy for initial staging of patients with low-grade NHL only in selected conditions and not for the general work-up.

【 授权许可】

Unknown